4.6 Article

Clinically relevant lessons from Family HealthLink: a cancer and coronary heart disease familial risk assessment tool

Journal

GENETICS IN MEDICINE
Volume 17, Issue 6, Pages 493-500

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/gim.2014.136

Keywords

familial; family history; genetic testing; risk assessment; triage

Funding

  1. OSU-WMC Comprehensive Cancer Center

Ask authors/readers for more resources

Purpose: A descriptive retrospective study was performed using two separate user cohorts to determine the effectiveness of Family HealthLink as a clinical triage tool. Methods: Cohort 1 consisted of 2,502 users who accessed the public website. Cohort 2 consisted of 194 new patients in a Comprehensive Breast Center setting. For patient users, we assessed documentation of family history and genetics referral. For all users seen in a genetics clinic, the Family HealthLink assessment was compared with that performed by genetic counselors and genetic testing outcomes. Results: For general public users, the percentage meeting high-risk criteria were: for cancer only, 22.2%; for coronary heart disease only, 24.3%; and for both diseases, 10.4%. These risk stratification percentages were similar for the patient users. For the patient users, there often was documentation of family history of certain cancer types by oncology professionals, but age of onset and coronary heart disease family history were less complete. Of 142 with high-risk assignments seen in a genetics clinic, 130 (91.5%) of these assignments were corroborated. Forty-two underwent genetic testing and 17 (40.5%) had new molecular diagnoses established. Conclusion: A significant percentage of individuals are at high familial risk and may require more intensive screening and referral. Interactive family history triage tools can aid this process.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Healthcare Costs Reduced After Incorporating the Results of the American College of Surgeons Oncology Group Z0011 Trial into Clinical Practice

Michelle M. Fillion, Katherine E. Glass, Joe Hayek, Allison Wehr, Gary Phillips, Alicia Terando, Doreen M. Agnese

BREAST JOURNAL (2017)

Article Oncology

ATM mutations for surgeons

Sara A. Mansfield, Robert Pilarski, Doreen M. Agnese

FAMILIAL CANCER (2017)

Article Genetics & Heredity

Counselees' Perspectives of Genomic Counseling Following Online Receipt of Multiple Actionable Complex Disease and Pharmacogenomic Results: a Qualitative Research Study

Kevin Sweet, Shelly Hovick, Amy C. Sturm, Tara Schmidlen, Erynn Gordon, Barbara Bernhardt, Lisa Wawak, Karen Wernke, Joseph McElroy, Laura Scheinfeldt, Amanda E. Toland, J. S. Roberts, Michael Christman

JOURNAL OF GENETIC COUNSELING (2017)

Article Oncology

Inflammatory Cytokines and Comorbidity Development in Breast Cancer Survivors Versus Noncancer Controls: Evidence for Accelerated Aging?

Catherine M. Alfano, Juan Peng, Rebecca R. Andridge, Monica E. Lindgren, Stephen P. Povoski, Adele M. Lipari, Doreen M. Agnese, William B. Farrar, Lisa D. Yee, William E. Carson, Janice K. Kiecolt-Glaser

JOURNAL OF CLINICAL ONCOLOGY (2017)

Article Genetics & Heredity

Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports

Kevin Sweet, Amy C. Sturm, Tara Schmidlen, Joseph McElroy, Laura Scheinfeldt, Kandamurugu Manickam, Erynn S. Gordon, Shelly Hovick, J. Scott Roberts, Amanda Ewart Toland, Michael Christman

JOURNAL OF GENETIC COUNSELING (2017)

Article Surgery

Surveillance strategies in the follow-up of melanoma patients: too much or not enough?

James Kurtz, Georgia M. Beasley, Doreen Agnese, Kari Kendra, Thomas E. Olencki, Alicia Terando, J. Harrison Howard

JOURNAL OF SURGICAL RESEARCH (2017)

Article Medicine, General & Internal

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

M. B. Faries, J. F. Thompson, A. J. Cochran, R. H. Andtbacka, N. Mozzillo, J. S. Zager, T. Jahkola, T. L. Bowles, A. Testori, P. D. Beitsch, H. J. Hoekstra, M. Moncrieff, C. Ingvar, M. W. J. M. Wouters, M. S. Sabel, E. A. Levine, D. Agnese, M. Henderson, R. Dummer, C. R. Rossi, R. I. Neves, S. D. Trocha, F. Wright, D. R. Byrd, M. Matter, E. Hsueh, A. MacKenzie-Ross, D. B. Johnson, P. Terheyden, A. C. Berger, T. L. Huston, J. D. Wayne, B. M. Smithers, H. B. Neuman, S. Schneebaum, J. E. Gershenwald, C. E. Ariyan, D. C. Desai, L. Jacobs, K. M. McMasters, A. Gesierich, P. Hersey, S. D. Bines, J. M. Kane, R. J. Barth, G. McKinnon, J. M. Farma, E. Schultz, S. Vidal-Sicart, R. A. Hoefer, J. M. Lewis, R. Scheri, M. C. Kelley, O. E. Nieweg, R. D. Noyes, D. S. B. Hoon, H. -J. Wang, D. A. Elashoff, R. M. Elashoff

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Oncology

Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?

Charles J. Puza, Srirama Josyula, Alicia M. Terando, John H. Howard, Doreen M. Agnese, Paul J. Mosca, Walter T. Lee, Georgia M. Beasley

JOURNAL OF SURGICAL ONCOLOGY (2018)

Article Oncology

Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond BRCA1 and BRCA2 in Breast and Ovarian Cancer Patients

Whitney Espinel, Marjan Champine, Heather Hampel, Joanne Jeter, Kevin Sweet, Robert Pilarski, Rachel Pearlman, Kate Shane, Pamela Brock, Judith A. Westman, Lindsay Kipnis, Jilliane Sotelo, Anu Chittenden, Samantha Culver, Jill E. Stopfer, Katherine A. Schneider, Rosalba Sacca, Diane R. Koeller, Shraddha Gaonkar, Erica Vaccari, Sarah Kane, Scott T. Michalski, Shan Yang, Sarah M. Nielsen, Sara L. Bristow, Stephen E. Lincoln, Robert L. Nussbaum, Edward D. Esplin

Summary: The study demonstrates that positive results from genetic testing for DDR genes beyond BRCA1 and BRCA2 can have clinical utility, impacting patient's clinical management and facilitating identification of at-risk carriers and treatment decisions.

CANCERS (2022)

Article Health Care Sciences & Services

Early Outcome Data Assessing Utility of a Post-Test Genomic Counseling Framework for the Scalable Delivery of Precision Health

Amy C. Sturm, Tara Schmidlen, Laura Scheinfeldt, Shelly Hovick, Joseph P. McElroy, Amanda E. Toland, J. Scott Roberts, Kevin Sweet

JOURNAL OF PERSONALIZED MEDICINE (2018)

Review Pathology

Minimal Clinical Impact of Intraoperative Examination of Sentinel Lymph Nodes in Patients With Ductal Carcinoma In Situ An Opportunity for Improved Resource Utilization

Eugene T. Shin, Amy S. Joehlin-Price, Doreen M. Agnese, Debra L. Zynger

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2017)

Article Oncology

The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma

Maris S. Jones, Peter C. Jones, Stacey L. Stern, David Elashoff, Dave S. B. Hoon, John Thompson, Nicola Mozzillo, Omgo E. Nieweg, Dirk Noyes, Harald J. Hoekstra, Jonathan S. Zager, Daniel F. Roses, Alessandro Testori, Brendon J. Coventry, Mark B. Smithers, Robert Andtbacka, Doreen Agnese, Erwin Schultz, Eddy C. Hsueh, Mark Kelley, Schlomo Schneebaum, Lisa Jacobs, Tawnya Bowles, Mohammed Kashani-Sabet, Douglas Johnson, Mark B. Faries

ANNALS OF SURGICAL ONCOLOGY (2017)

Article Oncology

Timing of Breast Cancer SurgeryHow Much Does It Matter?

Sara A. Mansfield, Mahmoud Abdel-Rasoul, Alicia M. Terando, Doreen M. Agnese

BREAST JOURNAL (2017)

Article Biochemical Research Methods

Plasma MicroRNA Levels Following Resection of Metastatic Melanoma

Nicholas Latchana, Zachary B. Abrams, J. Harrison Howard, Kelly Regan, Naduparambil Jacob, Paolo Fadda, Alicia Terando, Joseph Markowitz, Doreen Agnese, Philip Payne, William E. Carson

BIOINFORMATICS AND BIOLOGY INSIGHTS (2017)

Meeting Abstract Oncology

Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous Cell Carcinoma

G. Beasley, J. Kurtz, J. H. Howard, A. Terando, D. Agnese, L. David, T. Olencki

ANNALS OF SURGICAL ONCOLOGY (2017)

Article Genetics & Heredity

Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina

Katerina S. Kucera, Beth Lincoln Boyea, Brooke Migliore, Sarah Nelson Potter, Veronica R. Robles, Oksana Kutsa, Heidi Cope, Katherine C. Okoniewski, Anne Wheeler, Catherine W. Rehder, Edward C. Smith, Holly L. Peay

Summary: Screening for elevated CK-MM levels in dried blood spots is a feasible method to identify newborns with DMD. Including specific cutoffs, repeat testing, and genetic sequencing can improve the accuracy and sensitivity of screening.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Preparing for the unexpected: Recommendations for returning secondary findings in late-stage cancer care

Madeline Currey, Ilana Solomon, Sarah Mcgraw, Jenny Shen, Francisco Munoz, Ernesto Sosa, Vanessa Puello-Lozano, Sam Wing, Lisa Lopez, Michelle Afkhami, Janine Lobello, Szabolcs Szelinger, Stacy W. Gray

Summary: This study conducted qualitative interviews with cancer patients and providers to identify gaps in clinical care and propose care delivery solutions for the return of secondary germline findings. The responses of patients varied depending on the amount of pre-test counseling they received, and providers identified insufficient clinic time as a major barrier to pretest education. Online support tools and standardized pre-test education models were favored by providers. There were differing perspectives on how pre-test education should be integrated into clinical workflows, but agreement on the inclusion of differences between somatic and germline testing, likelihood of medically actionable findings, and the possibility of being referred to a genetics provider.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Genome sequencing detects a wide range of clinically relevant copy-number variants and other genomic alterations

Kiely N. James, Shimul Chowdhury, Yan Ding, Sergey Batalov, Kelly Watkins, Yong Hyun Kwon, Lucitia Van Der Kraan, Katarzyna Ellsworth, Stephen F. Kingsmore, Lucia Guidugli

Summary: This study used genome sequencing to detect a wide range of copy-number variants (CNVs) and other non-single nucleotide variant/indel variant types. These genetic alterations accounted for 15.8% of reported variants, with deletions being the most common type. The study also found that additional genetic tests were ordered in some cases, but failed to report the variants detected by genome sequencing.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Physician services and costs after disclosure of diagnostic sequencing results in the NYCKidSeq program

Asem Berkalieva, Nicole R. Kelly, Ashley Fisher, Samuel F. Hohmann, Monisha Sebastin, Miranda Di Biase, Katherine E. Bonini, Priya Marathe, Jacqueline A. Odgis, Sabrina A. Suckiel, Michelle A. Ramos, Rosamond Rhodes, Noura S. Abul-Husn, John M. Greally, Carol R. Horowitz, Melissa P. Wasserstein, Eimear E. Kenny, Bruce D. Gelb, Bart S. Ferket

Summary: The study aims to understand the effects of returning diagnostic sequencing results on clinical actions and economic outcomes for pediatric patients with suspected genetic disorders. The results showed that patients with positive findings were more likely to receive specialist consultation, but there were no significant increases in overall physician services and costs. More large-scale studies are needed to confirm these findings.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Incidence, prevalence, age at diagnosis, and mortality in individuals with 45,X/46,XY mosaicism: A population-based registry study

Kirstine Stochholm, Camilla Holmgard, Shanlee M. Davis, Claus H. Gravholt, Agnethe Berglund

Summary: This study assessed the incidence, prevalence, and age at diagnosis of individuals with 45,X/46,XY mosaicism and described the associated mortality pattern. The study found an increasing incidence of 45,X/46,XY mosaicism in males and a stable incidence in females. Males were diagnosed at an older age than females. Additionally, 45,X/46,XY mosaicism was associated with increased all-cause mortality.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

DLG2 intragenic exonic deletions reinforce the link to neurodevelopmental disorders and suggest a potential association with congenital anomalies and dysmorphism

Yunjia Chen, Ender Karaca, Nathaniel H. Robin, Dana Goodloe, Ali Al-Beshri, S. Joy Dean, Anna C. E. Hurst, Andrew J. Carroll, Fady M. Mikhail

Summary: This study confirms the association between DLG2 intragenic deletions and neurodevelopmental disorders, supports the haploinsufficiency of the DLG2 gene, and suggests a potential association between these deletions and congenital anomalies and dysmorphism.

GENETICS IN MEDICINE (2024)